Journalists and other readers should disregard the news release,PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population withHepatitis C, issued earlier today over PR Newswire, as it was issuedprematurely by PR Newswire. The release will be reissued later today.